You have 9 free searches left this month | for more free features.

R-ICE X

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib plus R-ICE, Decitabine plus R-ICE, Chidamide plus R-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus R-ICE
  • +4 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Apr 26, 2022

Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
  • (no location specified)
Sep 5, 2023

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,

Terminated
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Miami, Florida
    University of Miami
Aug 23, 2022

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Headington, Oxford, United Kingdom
  • +1 more
Nov 2, 2022

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 23, 2023

Diffuse Large B-cell-lymphoma Trial in Saint Louis, Cleveland (Venetoclax, Rituximab, Ifosfamide)

Active, not recruiting
  • Diffuse Large B-cell-lymphoma
  • Saint Louis, Missouri
  • +2 more
Nov 14, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Jacksonville, Florida
  • +11 more
Jan 12, 2023

Relapsed Diffuse Large B-cell Lymphoma, Refractory DLBCL Trial in Worldwide (Polatuzumab Vedotin, Mabthera, Ifosfamide)

Recruiting
  • Relapsed Diffuse Large B-cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Polatuzumab Vedotin
  • +4 more
  • Graz, Austria
  • +62 more
Aug 2, 2022

Sensory Block During Labour Epidural Analgesia in Patients

Recruiting
  • Labor Pain
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Jun 5, 2023

    Acne Scars - Mixed Atrophic and Hypertrophic, Ice Pick Scars, Rolling Scars Trial in Milano (Profhilo® Structura)

    Recruiting
    • Acne Scars - Mixed Atrophic and Hypertrophic
    • +3 more
    • Profhilo® Structura
    • Milano, Lombardia, Italy
      DERMING S.r.l., Clinical Research and Bioengineering Institute
    Jan 18, 2023

    Multiple Sclerosis Trial in Roscoff (partial-body cryotherapy chamber session)

    Recruiting
    • Multiple Sclerosis
    • partial-body cryotherapy chamber session
    • Roscoff, France
      Centre de Perharidy
    Sep 16, 2022

    Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • (no location specified)
    Apr 24, 2022

    Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • CD19x22 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    The Examination of Woman Generations' on Exercise Preferences,

    Not yet recruiting
    • Healthy Woman
    • Body Image
    • Assessment1
    • +4 more
    • (no location specified)
    Jun 18, 2023

    Breast Cancer, Sentinel Lymph Node, Breast Tumors Trial in Madison (drug, device, other)

    Recruiting
    • Breast Cancer
    • +3 more
    • Lidocaine patch
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin School of Medicine and Public Health
    Mar 8, 2022

    Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

    Recruiting
    • Relapsed/Refractory Peripheral T-cell Lymphoma
    • Relapsed/Refractory Classical Hodgkins Lymphoma
    • Duarte, California
    • +33 more
    Jan 5, 2023

    Adult Patients Treated in Study R5459-RT-1944 Who Receive A

    Not yet recruiting
    • Chronic Kidney Disease (CKD)
    • Noninterventional
    • (no location specified)
    Nov 21, 2022

    Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)

    Completed
    • Lymphoma, Large B-Cell, Diffuse
    • Gilbert, Arizona
    • +18 more
    Aug 19, 2022

    Atrial Fibrillation, Stroke Trial in Overland Park (Imaging guidance with TEE and ICE for Left atrial appendage closure)

    Recruiting
    • Atrial Fibrillation
    • Stroke
    • Imaging guidance with TEE and ICE for Left atrial appendage closure
    • Overland Park, Kansas
      Kansas City Heart Rhythm Institute - Roe Clinic
    Sep 25, 2023

    Bacterial Vaginosis, Vaginal Infection, Vaginal Diseases Trial in Czechia, Poland, Slovakia (Dequalinium Chloride, Metronidazole

    Terminated
    • Bacterial Vaginosis
    • +2 more
    • Dequalinium Chloride
    • Metronidazole Oral
    • Brno, Czechia
    • +13 more
    Mar 28, 2023

    Canadian Patients Receiving Dupixent® for Moderate to Severe

    Recruiting
    • Moderate to Severe Atopic Dermatitis
      • Toronto, Ontario, Canada
      • +1 more
      Oct 24, 2023

      Mental Health, Social Isolation, Loneliness Trial in Winnipeg (Hans Kai Program)

      Recruiting
      • Mental Health
      • +3 more
      • Hans Kai Program
      • Winnipeg, Manitoba, Canada
        NorWest Co-op Community Health
      Jan 18, 2023

      Children, Only, Pain, Emergencies Trial in Mersin (Cold spray, Refrigerated gel ice)

      Completed
      • Children, Only
      • +2 more
      • Cold spray
      • Refrigerated gel ice
      • Mersin, Turkey
        Tarsus University
      Oct 30, 2023

      EuroPainClinicsStudy X

      Recruiting
      • Back Pain
      • Retrospective observation after 24 months after the spinal procedure
      • +2 more
      • Bardejov, Slovakia
      • +2 more
      May 22, 2021

      DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

      Recruiting
      • Diffuse Large B-Cell Lymphoma (DLBCL)
      • Pembroke Pines, Florida
      • +3 more
      Jan 23, 2023